Additionally, CEA-targeting PLGA-PEG NPs loaded with paclitaxel have been demonstrated to selectively bind and trigger the death of CEA-expressing colorectal cancer cells [121]. The gene discussed is CEACAM5; the disease is colorectal cancer.